DEMINERALIZED BONE MATRIX MARKET ANALYSIS

Demineralized Bone Matrix Market Size and Trends

The Global Demineralized Bone Matrix Market is estimated to be valued at USD 1.41 Billion in 2024 and is expected to reach USD 2.15 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

To learn more about this report, request sample copy

The demineralized bone matrix market is expected to witness a positive growth trend over the forecast period. Rising number of sport injuries and bone and joint disorders such as osteoporosis and arthritis is expected to drive demand. In addition, increasing demand for bone graft substitutes and technological advancements in medical procedures are expected to provide new opportunities for market players. Stringent regulatory framework and high costs associated with bone grafting procedures may hamper market growth to some extent over the forecast period. However, growing elderly population prone to bone related issue will have significant impact on the demand.

Market Driver - Increasing demand for bone graft substitutes

The demand for bone graft substitutes is on a steady rise in the recent years. With increasing number of traumatic injuries, aging population and growing medical tourism industry, the number of orthopedic surgeries requiring bone grafts have seen a significant upward trend. Autografts have been traditionally considered as the gold standard for bone grafting procedures; however, harvesting autografts is an invasive procedure which causes donor site morbidity and limited graft material. This has fueled the need to explore alternative bone graft options with comparable healing properties but without the drawbacks of autografts.Demineralized bone matrix has emerged as one such favorable bone graft substitute capable of replacing autografts in many orthopedic procedures. It provides an off-the-shelf allograft material obtained from human cadaveric bone which is processed to retain only the organic components essential for bone regeneration. Without the mineral content, it resorbs slowly and promotes new bone formation. Demineralized bone matrix also carries significantly lower risk of disease transmission or immune responses unlike other allograft options. The ability of demineralized bone matrix to induce bone growth without donor site pain or constraints of material availability has made it a preferable choice for surgeons and patients alike over the past few years.

Rising Cases of Orthopedic Disorders and Injuries

Orthopedic conditions requiring bone grafts are on a surge worldwide. This can majorly be attributed to growing prevalence of osteoporosis, rising obesity levels and sedentary lifestyles leading to increased risk of fractures. Ageing population profile of many countries have further augmented the occurrence of orthopedic ailments. In addition, frequent traumatic injuries due to rising sports participation, urbanization and road accidents are posing a significant healthcare challenge. As per recent estimates by credible health organizations, musculoskeletal disorders already account for over 160 million disability days globally each year. With lengthening life expectancy and active ageing, orthogeriatric patients with complex osteoporotic fractures or spinal conditions are also rising fast. Developed regions are particularly impacted since osteoporosis and age-related bone fragility have reached epidemic proportions in these areas. At the same time, occurrence of injuries has doubled in low and middle-income countries according to data from past decade. All these trends collectively are driving greater demand for various orthopedic reconstruction procedures involving bone grafts on a worldwide scale. Demineralized bone matrix, with its proven integration and healing properties, is well-positioned to cater to this surging need for effective bone graft substitutes.